Loading the section…
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 |
|---|---|---|---|---|
| Research and development | 5M | 3M | 4M | 13M |
| Selling, general and administrative | 4M | 3M | 4M | 5M |
| Operating expenses | 9M | 6M | 7M | 18M |
| Net income | −10M | −8M | −7M | −18M |
| Earnings per share | 2.39 | 8.08 | 30.00 | 127.80 |
| Earnings per share, diluted | 2.39 | 8.08 | 30.00 | 127.80 |
| Weighted average shares | 4M | 930,822 | 230,795 | 139,682 |
| Weighted average shares, diluted | 4M | 930,822 | 230,795 | 139,682 |
| Metric | 18/08/2026 | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 |
|---|---|---|---|---|---|---|
| Cash and equivalents | — | 4M | 5M | 3M | — | — |
| Short-term investments | — | 7M | 7M | 8M | — | — |
| Current assets | — | 19M | 16M | 13M | — | — |
| Property, plant and equipment | — | — | — | 83,000 | — | — |
| Total assets | — | 19M | 19M | 17M | — | — |
| Current liabilities | — | 3M | 2M | 3M | — | — |
| Equity | — | 16M | 16M | 14M | 13M | 30M |
| Shares outstanding | — | 7M | 2M | 573,741 | — | — |
| Shares issued | — | 7M | 2M | 573,741 | — | — |
| Metric | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 |
|---|---|---|---|---|
| Operating cash flow | −6M | −6M | −6M | −19M |
| Depreciation and amortisation | — | 83,000 | 31,000 | 35,000 |
| Share-based compensation | 546,000 | 531,000 | 892,000 | 1M |
| Capital expenditure | — | — | — | 4,000 |
| Investing cash flow | −3M | −1M | 800,000 | 18M |
| Financing cash flow | 9M | 9M | 6M | 70,000 |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator